The Global Digital Sphygmomanometer Market size is expected to reach $1.3 billion by 2028, rising at a market growth of 4.9% CAGR during the forecast period.
A digital sphygmomanometer, also known as a blood pressure monitor or blood pressure gauge, is a device that is used to monitor blood pressure. The digital sphygmomanometer consists of an inflatable cuff to collapse and releases the artery in controlled manner. A digital sphygmomanometer has an inflatable cuff, a measuring unit, and a mechanism of inflation. Also, it has a digital meter that consists of oscillometric measurement and an electronic calculation.
The inflation while measuring blood pressure with this device can be done by using manual or automatic inflation. Yet, both types of inflation are electronic and are easy to use despite any training and can be used anywhere. The digital sphygmomanometer measures systolic and diastolic pressure with the help of oscillometric detection, which consists of either deformable membranes or differential piezoresistance. The digital sphygmomanometer measures the average blood pressure and pulse rate.
The measuring of systolic and diastolic pressure is more inaccurate than a manual meter. Some patients are suggested not to use digital sphygmomanometer especially those, with arteriosclerosis, arrhythmia, preeclampsia, pulsus alternans, and pulsus paradoxus as the calculation with digital oscillometric may not be correct with these conditions. The digital sphygmomanometer use a cuff placed as to provide accurate results, inverse order or profitability and convenience to the wrist and upper arm.
The oscillometric detection provides readings of the blood pressure different from the auscultation. The main advantage of using a digital sphygmomanometer is the comfort that it provides while operating. Digital sphygmomanometers are perfect for home monitoring of patients, especially when someone is measuring blood pressure by themselves.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Omron Corporation, Panasonic Holdings Corporation, Halma PLC, Baxter International, Inc., A&D HOLON Holdings Company, Limited, Contec Medical Systems Co., Ltd., Microlife AG (Midas Company Limited), Rossmax International Ltd., American Diagnostics Corporation and Yuwell-Jiangsu Yuyue medical equipment & supply Co., Ltd
A digital sphygmomanometer, also known as a blood pressure monitor or blood pressure gauge, is a device that is used to monitor blood pressure. The digital sphygmomanometer consists of an inflatable cuff to collapse and releases the artery in controlled manner. A digital sphygmomanometer has an inflatable cuff, a measuring unit, and a mechanism of inflation. Also, it has a digital meter that consists of oscillometric measurement and an electronic calculation.
The inflation while measuring blood pressure with this device can be done by using manual or automatic inflation. Yet, both types of inflation are electronic and are easy to use despite any training and can be used anywhere. The digital sphygmomanometer measures systolic and diastolic pressure with the help of oscillometric detection, which consists of either deformable membranes or differential piezoresistance. The digital sphygmomanometer measures the average blood pressure and pulse rate.
The measuring of systolic and diastolic pressure is more inaccurate than a manual meter. Some patients are suggested not to use digital sphygmomanometer especially those, with arteriosclerosis, arrhythmia, preeclampsia, pulsus alternans, and pulsus paradoxus as the calculation with digital oscillometric may not be correct with these conditions. The digital sphygmomanometer use a cuff placed as to provide accurate results, inverse order or profitability and convenience to the wrist and upper arm.
The oscillometric detection provides readings of the blood pressure different from the auscultation. The main advantage of using a digital sphygmomanometer is the comfort that it provides while operating. Digital sphygmomanometers are perfect for home monitoring of patients, especially when someone is measuring blood pressure by themselves.
COVID-19 Impact Analysis
The market for digital sphygmomanometers has been positively affected by the outspread of COVID-19. This is due to the increased adoption of digital sphygmomanometers for measuring blood pressure at home during the pandemic period. A wide population base has been advised to regularly measure the blood pressure, especially those with the long-term hypertension. This was to make sure that they may not get infected and also to reduce the risk of cross infections they may spread to healthcare workers measuring the blood pressure.Market Growth Factors
Rising need of home blood pressure monitoring
Over the previous few years, telehealth usage has increased. Patients quickly realized that there were additional advantages to telemedicine, despite the fact that the Covid-19 pandemic was the reason for the move from regular clinic visits to virtual ones. Telemedicine can deliver precise and prompt healthcare suggestions that were previously sought from a doctor. With this rising adoption of telehealth, the need for at home monitoring for health data such as blood pressure has become crucial.Growing prevalence of hypertension
The prevalence of hypertension has increased across the globe. The risk of developing heart, brain, kidney, and other disorders is dramatically increased by hypertension, often known as raised blood pressure. According to WHO; worldwide, 1.28 billion persons between the ages of 30 and 79 are projected to have hypertension, with the majority (two-thirds) residing in low- and middle-income nations. Adults with hypertension are reportedly 46% less likely to be aware of their condition.Market Restraining Factors
Growing competition in the market
One of the main issues impeding the growth of the digital sphygmomanometer market is the huge competition among suppliers and the prevalence of counterfeit goods. Due to the presence of numerous new and small businesses together with well-established vendors, the market has become very competitive. The majority of the digital sphygmomanometer are similar in design and technology and are available from both international and local providers. To increase their profit margins, multinational corporations make enormous investments in marketing, promotion, and brand-quality enhancement.Type Outlook
On the basis of type, the digital sphygmomanometer market is segmented into arm type and wrist type. In 2021, the wrist type segment garnered a substantial revenue share in digital sphygmomanometer market. Wrist digital sphygmomanometer is excellent for individuals with very large arms who do not have access to an arm cuff that fits properly. If so, wrist blood pressure measurement can be beneficial.End-User Outlook
Based on end user, the digital sphygmomanometer market is classified into hospitals & clinics, home care settings and others. In 2021, the hospitals & clinics segment held the highest revenue share in the digital sphygmomanometer market. The presence of vast numbers of patients in hospitals and clinics is estimated to support the market’s expansion in this segment.Regional Outlook
Region wise, the digital sphygmomanometer market is analyzed across North America, Europe, Asia pacific, and LAMEA. In 2021, the North America region witnessed the largest revenue share in the digital sphygmomanometer market. The rise in the adoption of digital sphygmomanometers by clinicians and patients, increasing number of patients with hypertension, and development in the healthcare sector are the factors propelling the growth of the digital sphygmomanometer market. In addition, the market is witnessing significant growth in the region due to high affordability of patients willing to invest in such devices.The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Omron Corporation, Panasonic Holdings Corporation, Halma PLC, Baxter International, Inc., A&D HOLON Holdings Company, Limited, Contec Medical Systems Co., Ltd., Microlife AG (Midas Company Limited), Rossmax International Ltd., American Diagnostics Corporation and Yuwell-Jiangsu Yuyue medical equipment & supply Co., Ltd
Strategies deployed in Digital Sphygmomanometer Market
- Nov-2022: OMRON Healthcare, Co., Ltd., a subsidiary company of Omron Corporation, came into partnership with CardioSignal, a mobile application, and a certified medical device. Through this partnership, both companies would aim to bring advancement in early cardiovascular detection of disease to help clinicians at beginning of Population Health management. Additionally, OMRON and CardioSignal would also aim to create digital health solutions that enhance workflow processes for lifestyle chronic diseases, primarily for cardiovascular disease detection at primary care by using OMRON's ECG and motion sensor technologies
- Jan-2022: OMRON Healthcare, Inc., a subsidiary of OMRON Corporation, launched Remote Patient Monitoring Services. The service would broaden Digital Health Services to support consumers on each step of their heart health journey. Moreover, this service is created to strengthen the guide behavior change, patient-physician connection, and reducing risk
- Dec-2021: OMRON Healthcare, a subsidiary of Omron Corporation, collaborated with Doctor Anywhere, a regional omnichannel healthcare platform. Under this Collaboration, Omron would integrate its portfolio of smart health monitoring devices with DA's telehealth platform. Additionally, this collaboration would digitally improve health management and remote hypertension program
- Dec-2021: Baxter completed the acquisition of Hillrom, a US-based equipment company, primarily into providing medical supplies and hospital equipment. The acquisition enhances Baxter's capability to serve clinicians, and patients worldwide, and further, open up growth opportunities for Baxter
- Nov-2021: Halma acquired Infinite Leap, the premier healthcare solutions provider. Under this acquisition, Infinite Leap would improve CenTrak’s capabilities as an end-to-end enterprise solutions company for healthcare organizations. In addition, this acquisition aimed to allow CenTrak to expand its solutions, services, and technologies to strengthen the increasing requirements of healthcare providers, especially big companies with networks of healthcare facilities, in the post-pandemic world
- Sep-2021: Baxter International, Inc. received FDA approval for premix Norepinephrine Bitartrate in 5% Dextrose Injection. The product consists of a ready-to-use formulation that enables hospitals to store this medication near patient care settings including intensive care units, surgical areas, and emergency departments to administer it faster and decrease the risk of touch contamination and compounding errors
- 2020-Jul: OMRON Healthcare teamed up with Mount Sinai Health System, New York City’s largest academic medical system. This collaboration aimed to provide patients with the new VitalSight home blood pressure monitoring solution
- 2018-Jan: Omron Healthcare, a subsidiary company of Omron Corporation, unveiled two heart monitoring devices including the Omron HeartGuide, a wearable oscillometric wrist blood pressure monitor watch, and the Omron Blood Pressure Monitor + EKG, a clinically validated blood pressure monitor. This launch is aimed decrease the impact of heart disease globally
Scope of the Study
Market Segments Covered in the Report:
By Type
- Arm Type
- Wrist Type
By End User
- Hospitals & Clinics
- Home Care Settings
- Others
By Geography
North America
- US
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Omron Corporation
- Panasonic Holdings Corporation
- Halma PLC
- Baxter International, Inc
- A&D HOLON Holdings Company, Limited
- Contec Medical Systems Co., Ltd
- Microlife AG (Midas Company Limited)
- Rossmax International Ltd
- American Diagnostics Corporation
- Yuwell-Jiangsu Yuyue medical equipment & supply Co., Ltd
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Digital Sphygmomanometer Market, by Type
1.4.2 Global Digital Sphygmomanometer Market, by End User
1.4.3 Global Digital Sphygmomanometer Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Digital Sphygmomanometer Market
Chapter 4. Global Digital Sphygmomanometer Market by Type
4.1 Global Arm Type Market by Region
4.2 Global Wrist Type Market by Region
Chapter 5. Global Digital Sphygmomanometer Market by End User
5.1 Global Hospitals & Clinics Market by Region
5.2 Global Home Care Settings Market by Region
5.3 Global Others Market by Region
Chapter 6. Global Digital Sphygmomanometer Market by Region
6.1 North America Digital Sphygmomanometer Market
6.1.1 North America Digital Sphygmomanometer Market by Type
6.1.1.1 North America Arm Type Market by Country
6.1.1.2 North America Wrist Type Market by Country
6.1.2 North America Digital Sphygmomanometer Market by End User
6.1.2.1 North America Hospitals & Clinics Market by Country
6.1.2.2 North America Home Care Settings Market by Country
6.1.2.3 North America Others Market by Country
6.1.3 North America Digital Sphygmomanometer Market by Country
6.1.3.1 US Digital Sphygmomanometer Market
6.1.3.1.1 US Digital Sphygmomanometer Market by Type
6.1.3.1.2 US Digital Sphygmomanometer Market by End User
6.1.3.2 Canada Digital Sphygmomanometer Market
6.1.3.2.1 Canada Digital Sphygmomanometer Market by Type
6.1.3.2.2 Canada Digital Sphygmomanometer Market by End User
6.1.3.3 Mexico Digital Sphygmomanometer Market
6.1.3.3.1 Mexico Digital Sphygmomanometer Market by Type
6.1.3.3.2 Mexico Digital Sphygmomanometer Market by End User
6.1.3.4 Rest of North America Digital Sphygmomanometer Market
6.1.3.4.1 Rest of North America Digital Sphygmomanometer Market by Type
6.1.3.4.2 Rest of North America Digital Sphygmomanometer Market by End User
6.2 Europe Digital Sphygmomanometer Market
6.2.1 Europe Digital Sphygmomanometer Market by Type
6.2.1.1 Europe Arm Type Market by Country
6.2.1.2 Europe Wrist Type Market by Country
6.2.2 Europe Digital Sphygmomanometer Market by End User
6.2.2.1 Europe Hospitals & Clinics Market by Country
6.2.2.2 Europe Home Care Settings Market by Country
6.2.2.3 Europe Others Market by Country
6.2.3 Europe Digital Sphygmomanometer Market by Country
6.2.3.1 Germany Digital Sphygmomanometer Market
6.2.3.1.1 Germany Digital Sphygmomanometer Market by Type
6.2.3.1.2 Germany Digital Sphygmomanometer Market by End User
6.2.3.2 UK Digital Sphygmomanometer Market
6.2.3.2.1 UK Digital Sphygmomanometer Market by Type
6.2.3.2.2 UK Digital Sphygmomanometer Market by End User
6.2.3.3 France Digital Sphygmomanometer Market
6.2.3.3.1 France Digital Sphygmomanometer Market by Type
6.2.3.3.2 France Digital Sphygmomanometer Market by End User
6.2.3.4 Russia Digital Sphygmomanometer Market
6.2.3.4.1 Russia Digital Sphygmomanometer Market by Type
6.2.3.4.2 Russia Digital Sphygmomanometer Market by End User
6.2.3.5 Spain Digital Sphygmomanometer Market
6.2.3.5.1 Spain Digital Sphygmomanometer Market by Type
6.2.3.5.2 Spain Digital Sphygmomanometer Market by End User
6.2.3.6 Italy Digital Sphygmomanometer Market
6.2.3.6.1 Italy Digital Sphygmomanometer Market by Type
6.2.3.6.2 Italy Digital Sphygmomanometer Market by End User
6.2.3.7 Rest of Europe Digital Sphygmomanometer Market
6.2.3.7.1 Rest of Europe Digital Sphygmomanometer Market by Type
6.2.3.7.2 Rest of Europe Digital Sphygmomanometer Market by End User
6.3 Asia Pacific Digital Sphygmomanometer Market
6.3.1 Asia Pacific Digital Sphygmomanometer Market by Type
6.3.1.1 Asia Pacific Arm Type Market by Country
6.3.1.2 Asia Pacific Wrist Type Market by Country
6.3.2 Asia Pacific Digital Sphygmomanometer Market by End User
6.3.2.1 Asia Pacific Hospitals & Clinics Market by Country
6.3.2.2 Asia Pacific Home Care Settings Market by Country
6.3.2.3 Asia Pacific Others Market by Country
6.3.3 Asia Pacific Digital Sphygmomanometer Market by Country
6.3.3.1 China Digital Sphygmomanometer Market
6.3.3.1.1 China Digital Sphygmomanometer Market by Type
6.3.3.1.2 China Digital Sphygmomanometer Market by End User
6.3.3.2 Japan Digital Sphygmomanometer Market
6.3.3.2.1 Japan Digital Sphygmomanometer Market by Type
6.3.3.2.2 Japan Digital Sphygmomanometer Market by End User
6.3.3.3 India Digital Sphygmomanometer Market
6.3.3.3.1 India Digital Sphygmomanometer Market by Type
6.3.3.3.2 India Digital Sphygmomanometer Market by End User
6.3.3.4 South Korea Digital Sphygmomanometer Market
6.3.3.4.1 South Korea Digital Sphygmomanometer Market by Type
6.3.3.4.2 South Korea Digital Sphygmomanometer Market by End User
6.3.3.5 Singapore Digital Sphygmomanometer Market
6.3.3.5.1 Singapore Digital Sphygmomanometer Market by Type
6.3.3.5.2 Singapore Digital Sphygmomanometer Market by End User
6.3.3.6 Malaysia Digital Sphygmomanometer Market
6.3.3.6.1 Malaysia Digital Sphygmomanometer Market by Type
6.3.3.6.2 Malaysia Digital Sphygmomanometer Market by End User
6.3.3.7 Rest of Asia Pacific Digital Sphygmomanometer Market
6.3.3.7.1 Rest of Asia Pacific Digital Sphygmomanometer Market by Type
6.3.3.7.2 Rest of Asia Pacific Digital Sphygmomanometer Market by End User
6.4 LAMEA Digital Sphygmomanometer Market
6.4.1 LAMEA Digital Sphygmomanometer Market by Type
6.4.1.1 LAMEA Arm Type Market by Country
6.4.1.2 LAMEA Wrist Type Market by Country
6.4.2 LAMEA Digital Sphygmomanometer Market by End User
6.4.2.1 LAMEA Hospitals & Clinics Market by Country
6.4.2.2 LAMEA Home Care Settings Market by Country
6.4.2.3 LAMEA Others Market by Country
6.4.3 LAMEA Digital Sphygmomanometer Market by Country
6.4.3.1 Brazil Digital Sphygmomanometer Market
6.4.3.1.1 Brazil Digital Sphygmomanometer Market by Type
6.4.3.1.2 Brazil Digital Sphygmomanometer Market by End User
6.4.3.2 Argentina Digital Sphygmomanometer Market
6.4.3.2.1 Argentina Digital Sphygmomanometer Market by Type
6.4.3.2.2 Argentina Digital Sphygmomanometer Market by End User
6.4.3.3 UAE Digital Sphygmomanometer Market
6.4.3.3.1 UAE Digital Sphygmomanometer Market by Type
6.4.3.3.2 UAE Digital Sphygmomanometer Market by End User
6.4.3.4 Saudi Arabia Digital Sphygmomanometer Market
6.4.3.4.1 Saudi Arabia Digital Sphygmomanometer Market by Type
6.4.3.4.2 Saudi Arabia Digital Sphygmomanometer Market by End User
6.4.3.5 South Africa Digital Sphygmomanometer Market
6.4.3.5.1 South Africa Digital Sphygmomanometer Market by Type
6.4.3.5.2 South Africa Digital Sphygmomanometer Market by End User
6.4.3.6 Nigeria Digital Sphygmomanometer Market
6.4.3.6.1 Nigeria Digital Sphygmomanometer Market by Type
6.4.3.6.2 Nigeria Digital Sphygmomanometer Market by End User
6.4.3.7 Rest of LAMEA Digital Sphygmomanometer Market
6.4.3.7.1 Rest of LAMEA Digital Sphygmomanometer Market by Type
6.4.3.7.2 Rest of LAMEA Digital Sphygmomanometer Market by End User
Chapter 7. Company Profiles
7.1 Omron Corporation
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Product Launches and Product Expansions:
7.1.6 SWOT Analysis
7.2 Panasonic Holdings Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 SWOT Analysis
7.3 Halma PLC
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Acquisition and Mergers:
7.4 Baxter International, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Approvals and Trials:
7.4.5.2 Acquisition and Mergers:
7.5 A&D HOLON Holdings Company, Limited
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.6 Contec Medical Systems Co., Ltd.
7.6.1 Company Overview
7.7 Microlife AG (Midas Company Limited)
7.7.1 Company Overview
7.8 Rossmax International Ltd.
7.8.1 Company Overview
7.9 American Diagnostic Corporation
7.9.1 Company Overview
7.10. Yuwell-Jiangsu Yuyue medical equipment & supply Co., Ltd
7.10.1 Company Overview
Companies Mentioned
- Omron Corporation
- Panasonic Holdings Corporation
- Halma PLC
- Baxter International, Inc.
- A&D HOLON Holdings Company, Limited
- Contec Medical Systems Co., Ltd.
- Microlife AG (Midas Company Limited)
- Rossmax International Ltd.
- American Diagnostics Corporation
- Yuwell-Jiangsu Yuyue medical equipment & supply Co., Ltd
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 149 |
| Published | January 2023 |
| Forecast Period | 2021 - 2028 |
| Estimated Market Value ( USD | $ 915.2 Million |
| Forecasted Market Value ( USD | $ 1268.5 Million |
| Compound Annual Growth Rate | 4.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
